-
Proportion of simulations (%) in the quadrants of the ICER scatterplot.
Proportion of simulations (%) in the quadrants of the ICER scatterplot. -
r37980778c78--c8883d2e0e4c9c88f9195b6b8d397cf9
Overview of current STIKO recommendation and hypothetical strategies (#1 to#3). -
Age and risk level specific medical and non-medical costs<sup>b</sup>.
Age and risk level specific medical and non-medical costsb. -
r37980778c78--72fb190979b9bc0ed90a34bc33fd4a8a
The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in The Netherlands in 2006 and was replaced by PHiD-CV10 in 2011. Data on carriage prevalence of S. pneumoniae... -
r37980778c78--707a6cf2501bb6065b772833ed7ea0ab
Odds ratios for invasive disease potential of serotypes were calculated using nationwide IPD data (children <5 years) and carriage data (24-month-old children) from 2004–2016. -
Estimating the cost-effectiveness of a sequential pneumococcal vaccination pr...
IntroductionIn Germany, a 23-valent polysaccharide pneumococcal vaccine (PPSV23) is recommended for elderly (60+) and patients 16+ with chronic diseases not associated with... -
Age and risk level specific demographic and epidemiological parameters.
Age and risk level specific demographic and epidemiological parameters. -
Characteristics of the 24-month-old children of all five studies.
Characteristics of the 24-month-old children of all five studies.
